Mineralys Therapeutics, Inc. (MLYS)
(Real Time Quote from BATS)
$13.92 USD
+0.22 (1.61%)
Updated Oct 16, 2024 03:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.83 |
EPS Last Quarter | -0.83 |
Last EPS Surprise | -13.70% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.08 |
Next Year | -3.39 |
EPS (TTM) | -2.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.83 | -0.86 | -3.08 | -3.39 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.83 | -0.84 | -3.22 | -3.48 |
High Estimate | -0.80 | -0.84 | -2.59 | -3.32 |
Low Estimate | -0.85 | -0.88 | -3.28 | -3.48 |
Year ago EPS | -0.57 | -0.61 | -1.99 | -3.08 |
Year over Year Growth Est. | -45.61% | -40.98% | -54.77% | -10.04% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.83 | -0.86 | -3.08 | -3.39 |
7 Days Ago | -0.83 | -0.86 | -3.08 | -3.39 |
30 Days Ago | -0.83 | -0.86 | -3.08 | -3.39 |
60 Days Ago | -0.83 | -0.86 | -3.08 | -3.39 |
90 Days Ago | -0.78 | -0.81 | -2.92 | -3.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.83 | -0.86 | -3.08 | -3.39 |
Zacks Consensus Estimate | -0.83 | -0.86 | -3.08 | -3.39 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.83 | -0.70 | -0.61 | -0.57 | NA |
Estimate | -0.73 | -0.68 | -0.85 | -0.72 | NA |
Difference | -0.10 | -0.02 | 0.24 | 0.15 | 0.07 |
Surprise | -13.70% | -2.94% | 28.24% | 20.83% | 8.11% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more